Neuronetics announces expanded TMS access through United HealthCare

Neuronetics (STIM) announced that United HealthCare (UNH) has updated their Medicare Advantage policy in states covered by National Government Services Medicare. This policy expansion increases access for patients to the company’s NeuroStar Advanced Therapy for Mental Health by adopting the recently announced NGS Medicare criteria allowing non-physician practitioners, like nurse practitioners, to order and administer TMS Therapy to their patients with major depressive disorder in states where they have scope of practice to do so. "It feels as though we’re at a tipping point with both commercial and government payers in their support for mental health coverage, including access to TMS Therapy," stated Keith J. Sullivan, President, and CEO of Neuronetics Inc. "Our health policy team is unwavering in their efforts and commitment to collaborating with NeuroStar providers and payers, and it’s exciting to see these continuing coverage trends."